Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting.

Lionel FalcheroNicolas MeyerOlivier MolinierFaraj Al FreijatHervé PegliascoEmmanuelle LecuyerLuc StovenLaure BelmontSandrine LoutskiCécile MaincentAnne-Sophie Blanchet-LegensAlexa MairovitzFatima MeniaiStéphane HominalAlexia LetierceHugues MorelDidier Debieuvre

Published in: European journal of cancer (Oxford, England : 1990) (2024)

The proportion with SCLC has decreased over time, but the proportion of women has increased. The 1-year OS rates have improved over 20 years. The KBP-2020 cohort suggests a benefit of immunotherapy on OS in patients with ES-SCLC in the real-life setting.

Keyphrases

small cell lung cancer
polycystic ovary syndrome
cross sectional
brain metastases
type diabetes
free survival
insulin resistance
glycemic control
weight loss